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INTRODUCTION
Human skin is constantly at risk of damage with exposure
to environmental insults including microbial challenge and
ultraviolet irradiation (1). So innate immune system may
immediately respond to intruding microbes for prevention
of further invasion, although stratum corneum is the first
line of defense. Antimicrobial peptides (AMPs), which is a
kind of innate immune system, can be isolated from various
tissues including respiratory, urogenital, and skin epithelium
(2, 3). In mammals, several AMPs such as defensins, cathe-
licidins, cecropins, histatins, lactoferrins, NK-lysin, and pro-
tegrins have been found (1, 4, 5). These peptides, which are
produced by keratinocytes in the skin, can disrupt the mem-
brane of the target microbe or penetrate the microbial mem-
brane, interfering with intracellular functions (1-5). The mech-
anisms that regulate expressions of AMPs are not yet under-
stood. Recently, however, Toll-like receptor (TLR) 2 and TLR
4 have been suggested to be related with the expressions of
these AMPs (6, 7).
Among numerous antimicrobial peptides, human  -de-
fensin (HBD) and cathelicidin are the major peptides in mam-
malian skin and they can be induced by injury or inflamma-
tion of the skin (1, 8-10). In humans, the cathelicidin family
is known to contain just a single member, LL-37 (9, 10).
Precise roles of HBD and LL-37 for the protection of UV-
induced damage in the skin are less well understood. Yang
et al. (11) reported that HBD may recruit immature dendritic
cells and memory T cells through their interaction with che-
mokine receptor 6 (CCR6) and therefore play important roles
in both innate and adaptive immune responses.
Atopic dermatitis and psoriasis, the common inflamma-
tory skin diseases, show contrasting disease features although
both diseases are characterized by defective skin barrier (12).
About 30 percent of patients with atopic dermatitis have
bacterial or viral infections of the skin, as compared with only
7 percent of patients with psoriasis (13). This fact is due to
distinct profile of chemokines and incoming helper T cell
types, and difference of epidermal thickness (13). In psoria-
sis, epidermis is thickened owing to increased and accelera-
tive differentiating keratinocytes. So, quantitatively, abun-
dant antimicrobial peptides are expressed in the epidermal
layer of psoriasis (12, 14).
Normal human keratinocytes (NHK) which are normally
differentiated cell and HaCaT cells which are immortalized,
rarely differentiated keratinocyte cell lines show different
differentiation feature. So, we designed this study to identify
the expressions of LL-37 in NHK and HaCaT cells after expo-
sure to stimulants in order to elucidate their roles for environ-
mental insults and to investigate the level of LL-37 expres-
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Expression and Modulation of LL-37 in Normal Human Keratinocytes,
HaCaT cells, and Inflammatory Skin Diseases
Defensins and cathelicidins (LL-37) are major antimicrobial peptides (AMPs) of the
innate immune system of the human skin. In normal non-inflamed skin these pep-
tides are negligible, but their expression can be markedly increased in inflammatory
skin disease such as psoriasis. We designed this study to identify the expressions
of LL-37 in normal human keratinocyte (NHK) and HaCaT cells after exposure to
stimulants and to investigate difference of LL-37 expression accompanied with cell
differentiation status, and come to understand difference of susceptibility to infection
in atopic dermatitis and psoriasis. Expressions of LL-37 in NHKs and HaCaT cells
were evaluated by using RT-PCR, Western blotting, and immunohistochemical (IHC)
staining at 6, 12, and 24 hr post stimulation after exposure to Ultraviolet B irradiation
and lipopolysaccharide. And expression of LL-37 in skin biopsy specimens from
patients with atopic dermatitis and psoriasis was determined by immunohistochemi-
cal analysis. In time-sequential analyses of LL-37 expression revealed that LL-37
was expressed in NHKs, but not in HaCaT cells. IHC analysis confirmed the pres-
ence of abundant LL-37 in the epidermis of psoriasis. Therefore we deduced that
expression of LL-37 is affected by UV irradiation, bacterial infection, and status of
cell differentiation. 
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sion accompanied with cell differentiation status and come
to understand difference of susceptibility to infection in atopic
dermatitis and psoriasis.
MATERIALS AND METHODS
HaCaT cell culture
The HaCaT cells, human keratinocyte cell lines, were cul-
tured in Isocove’s Modified Dulbecco’s Medium (IMDM)
(Gibco, Carlsbad, CA, U.S.A.), supplemented with 10% fetal
bovine serum (Gibco) and penicillin-streptomycin 100 IU-
100  g/mL (Gibco) grown on 75 cm2 flask and incubated
with 5% CO2 at 37℃. Cultured HaCaT cells were divided
as a number of 2×105/mL and plated in a standard flat bot-
tomed 10 cm2 polystyrene plate. Cells were starved in IMDM
supplemented with free fetal bovine serum overnight, some
cells then were irradiated Ultraviolet B (UVB) 20 mJ/cm2
and treated lipopolysaccharide (LPS) 2.5  g/mL, 5.0  g/mL
(Sigma, St. Louis, MO, U.S.A.) respectively and incubated
for 6, 12, and 24 hr.
Normal human keratinocytes
For harvesting NHKs, neonatal foreskin was obtained from
neonatal circumcision specimen and then primary culture
was done. Briefly, neonatal foreskin was chopped in 1 mm
size and trypsinized in room temperature overnight. After
vortex vigorously and incubated for 5 min and supernatant
was taken and plated on 25 cm2 culture flask and then incu-
bated 5% CO2 at 37℃ in keratinocyte growth media (Clo-
netics, East Rutherford, NJ, U.S.A.). Cultured normal human
keratinocytes were irradiated in UVB 20 mJ/cm2 and treat-
ed LPS 2.5  g/mL, 5.0  g/mL, respectively and incubated
for 6, 12, and 24 hr. 
Ultraviolet B irradiation
Dosage of irradiation was 20 mJ/cm2 which were chosen
based on preliminary data in this experiment. UVB irradia-
tion was delivered with a Philips TL 20W/12 (Eindhoven,
Netherlands), a fluorescent bulb emitting 280-320 nm wave
with a peak at 313 nm wave. Before UVB irradiation, medi-
um was removed and covered with phosphate buffered saline
(PBS). Irradiation output was monitored by means of a Wald-
mann UV-meter (Waldmann, Villigen-Schwenningen, Ger-
many). 
Lipopolysaccharide stimulation
2.5  g/mL and 5.0  g/mL of LPS (Sigma, St. Louis, MO,
U.S.A.) was used.
Preparation of primer
We synthesized the PCR primer from the basis of Gen-
Bank data. Primers were chemically synthesized by using
DNA synthesizer (Pharmacia, Bj rkgatan, Uppsala, Sweden).
Their sequences were as follows:
LL-37 (348 bp) :
5′ -TCG GAT GCT AAC CTC TAC CG-3′ (sense), 
5′ -GGG TAC AAG ATT CCG CAA AA-3′ (anti-sense) 
GAPDH (593 bp) : 
5′ -CCA CCC ATG GCA AAT TCC ATG GCA-3′ (sense),
5′ -GGT GCT GCT TGT TAG GAG GTC AAG TAA
AGG GC-3′ (anti-sense)
Reverse transcription-polymerase chain reaction
Total RNA was isolated from NHKs and HaCaT cells
using TRIZol reagent (Invitrogen, Carlsbad, CA, U.S.A.),
cells were added 1 mL of TRIZol reagent in cultured dish.
After 5 min at room temperature, added 0.2 mL of chloro-
form per 1 mL of TRIZol reagent, shook tubes vigorously
by hands for 15 sec and incubated them at 15℃to 30℃for
3 min. The mixtures were centrifuged with 12,000 rpm at
4℃ for 15 min, transferred the upper aqueous phase to a fresh
tube, and the same amount of 2-propanol was added. After
mixtures were incubated at 4℃for 15 min, it was centrifuged
with 12,000 rpm at 4℃ for 15 min. The supernatant was
removed, then washed 500  L of 70% ethanol with 12,000
rpm at 4℃for 5 min, the RNA pellet was briefly dried. The
purified RNA was dissolved in DEPC-DW 30  L. 3  g of
total cellular RNA was reverse transcribed at 42℃ for 30
min in a 20  L volume containing 1  L reverse transcriptase
(TaKaRa, Shiga, Japan), 10× buffer 2  L, 10 mM dNTP 2
L (dNTP mix), oligo dT primer 1  L, RNase inhibitor 0.5
L, 25 mM MgCl2 4  L. 2  L of each cDNA sample from
the RT-PCR was amplified by PCR in 25  L containing 10×
buffer 2.5  L, 25 mM MgCl2 2.5  L and 10 pmol 0.75  L
primer 
Reactions were cycled 35 times with denaturation at 94℃
for 1 min followed by annealing at 59℃for 1 min and finally
an extension step at 72℃for 1 min.
Electrophoresis
The products were run on 1.5% agarose gel containing 1  g
ethidium bromide per millimeter. 20  L of reaction mixture
was mixed with loading buffer separated by electrophoresis
for 15 min at 100 voltages and visualized by UV transillu-
mination. 
Quantitative analysis
It has been quantitatively analyzed with densitometer thatExpression and Modulation of LL-37 651
hybrids of PCR products of LL-37 and GAPDH on DIG
chemiluminescent film were calculated (volume of LL-37/
volume of GAPDH ×100).
Western blotting
NHK and HaCaT cell were lysed in a buffer containing 50
mM Tris-Cl (pH 8.0), 150 mM NaCl, 0.02% sodium azide,
100  g/mL phenylmethanesulfonyl fluoride (PMSF), 1  g/
mL aprotinin, 1% Triton ×100, centrifuged with 12,000
rpm at 4℃for 30 min.
The supernatant was transferred into new tube, 30  g of
soluble protein were loaded in 15% sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) with sam-
ple buffer containing 1 M Tris, glycerol 50%, samples were
heated at 95℃for 5 min prior to gel loading.
For LL-37 dectection, separated protein on gel electrophore-
sis was transferred to nitrocellulose membrane (Osmonics,
Minnesota, MN, U.S.A.) at 0.16A for 1 hr. The membrane
were washed 3 times with Tris-buffered saline Tween 20
(TBST), and blocked with 5% skim milk for 1 hr at room
temperature. Following this, the membrane were incubated
overnight at 4℃ with goat anti human LL-37 polyclonal
antibody (1:1,500 in 5% bovine serum albumin, SantaCruz,
Delaware, CA, U.S.A.) and then washed 3 times with TBST.
The secondary mouse anti-goat peroxidase conjugated anti-
body (1:2,000 in blocking solution, SantaCruz) was incubat-
ed for 1 hr at room temperature. 
After washing the membrane with TBST, the membrane
was developed with ECL solution (SantaCruz) for 3 min then
exposed to radiography film (Roche, Indianapolis, IN, U.S.A.).
Immunohistochemistry (IHC) for LL-37
The HaCaT cells and NHKs were cultured on coverslip
(Nunc, Rochester, NY, U.S.A.); the cells were fixed for 10
min in 4% paraformaldehyde and washed 3 times for 5 min
with PBS. Endogenous peroxidase was inactivated by incu-
bating 3% hydrogen peroxide at room temperature for 5 min,
and blocked with 3% BSA for 20 min then washing. Cells
were incubated overnight at 4℃ with goat anti-LL-37 poly-
clonal antibody, the primary antibody was diluted 1:50 in
PBS, rinsed three times with PBS and incubated with mouse
anti goat peroxidase-confugated antibody (1:200 in PBS) for
1 hr at room temperature. After washing 3 times, cells were
immersed in 3,3′ -diaminobenzidine (DAKO, Glostrup, Den-
mark), rinsed in distilled water.
Also immunohistochemical staining was carried out using
sections of paraffin-embedded tissues of psoriasis and atopic
dermatitis. Briefly, sections 4  m thick were deparaffinized
in xylene three times for 5 min each time, and epitopes were
retrieved by autoclaving (121℃) for 10 min in citrate-buffered
saline (pH 6.0). After cooling for 20 min at room tempera-
ture, endogenous peroxidase activities were quenched with
3% H2O2 treatment for 5 min. Sections were blocked with
normal goat serum for 1 hr and incubated with goat anti-
human LL-35 polyclonal antibody (1:200 dilution in PBS).
After five washes with PBS, sections were incubated with
peroxidase-conjugated anti-goat secondary antibody, and
color was developed with diaminobenzidine.
Statistical analysis
The amount of LL-37 expression in NHK and HaCaT cell
between unstimulated control and stimulated groups were
statistically compared using t-test.
RESULTS
RT-PCR
Expression of LL-37 mRNA in HaCaT cells was not detect-
ed in unstimulated control. Moreover, in UVB irradiation
and LPS stimulated groups, expressions of LL-37 mRNA
were not observed in HaCaT cells (data not shown). 
However, those in NHKs were upregulated by UVB irra-
diation and LPS stimulation (Fig. 1). At 6, 12 hr post stim-
ulation, LL-37 mRNA expressions were more markedly up-
regulated by LPS 2.5  g/mL and at 24 hr, by UVB 20 mJ/
cm2. These results were statistically significant compared to
control group (p<0.001).
Western blotting
Expression of LL-37 protein in NHKs was evaluated by
Western blotting study using polyclonal antibody to LL-37
at 6, 12, and 24 hr after stimulation (Fig. 2). The expres-
sion amounts of LL-37 protein in UVB irradiated and LPS
treated groups were shown more intense than those of un-
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Fig. 1. RT-PCR for LL-37 mRNA from normal human keratinocytes
(NHK) at 6 hr, 12 hr, and 24 hr after stimulation. CON, control; UVB
20, UVB 20 mJ/cm2; LPS 25, LPS (2.5  g/mL); LPS 50, LPS (5.0
g/mL). *Statistically significant compared to control group (p<
0.001).652 J.E. Kim, B.J. Kim, M.S. Jeong, et al.
stimulated control group. Expression of LL-37 band were
more intense in 6 hr, 12 hr after stimulation than 24 hr after
stimulation. But expressions of LL-37 protein in HaCaT
cells were not detected by Western blotting study (data not
shown).
Immunohistochemistry
The expressions of LL-37 protein in NHKs were determined
by IHC analysis. In NHKs, expressions of LL-37 protein of
UVB irradiated and LPS stimulated groups were more strongly
stained than those of unstimulated groups (Fig. 3). Expres-
sions of LL-37 protein in HaCaT cells were not detected by
IHC study using polyclonal antibody to LL-37 at 6, 12, and
24 hr after stimulation (data not shown). Also IHC confirmed
the presence of abundant LL-37 in the epidermis of psoriasis.
The sample from psoriatic lesions had much more intense
staining for LL-37 than sample from atopic dermatitis lesions
(Fig. 4). 
DISCUSSION
Naturally occurring AMPs are critical component of innate
immune system which provide mammalian skin protection
against invasive bacterial infection and other environmental
insults including UV irradiation, toxin, extreme temperature
etc. (1, 2). In human, the two main antimicrobial peptide fam-
ilies are defensins and cathelicidins. The two defensin subfam-
ilies,  - and  -defensins, differ in the length of peptide seg-
ments between the six cysteines and the pairing of the cys-
teines that are connected by disulphide bonds (8). The  -
defensins are abundant in neutrophil granules and Paneth
cells. The  defensins have been classified to  defensin 1,
2, 3, and 4 which can be expressed constitutively or after expo-
sure to stimulants (3). Until now many studies have been
reported regarding defensins and those of cathelicidins are
less reported in comparison with defensins (4, 5). So, we in-
tended to elucidate that inducible expression of LL-37 after
exposure to different experimental conditions and their role
in skin immunity against various environmental insults includ-
ing bacterial infection and UV irradiation in this study.
The term ‘cathelicidin’ was introduced in 1995 to encom-
pass bipartite molecules containing both cathelin domain
and C-terminal antimicrobial peptide domain (6). Catheli-
cidins are widely expressed family of mammalian antimicro-
bial peptides and like many such molecules are synthesized
as a preproprotein. This preproprotein consists of highly con-
served signal sequence and cathelin domain but have substan-
tial heterogeneity between species in the C-terminal domain
NHK
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Fig. 3. Immunohistochemical study using polyclonal antibody to
LL-37 in NHKs at 12 hr after stimulation. CON, control; UVB 20, UVB
20 mJ/cm
2; LPS 25, LPS (2.5  g/mL); LPS 50, LPS (5.0  g/mL)
(×200).
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Fig. 2. Expression of LL-37 protein in NHKs by Western blotting
study using polyclonal antibody to LL-37 at 6 hr, 12 hr, and 24 hr
after stimulation. CON, control; UVB 20, UVB 20 mJ/cm2; LPS 25,
LPS (2.5  g/mL); LPS 50, LPS (5.0  g/mL).
Fig. 4. Immunostaining for LL-37 in frozen skin sections from patients with psoriasis and atopic dermatitis. The arrow indicate immune reac-
tivity to LL-37 (×200).
A B Psoriasis Atopic dermatitisencoding the mature active peptide. Porcine and bovine neu-
trophils contain a variety of cathelicidins, whereas there is the
only one cathelicidin in human known as human cationic
antimicrobial peptide 18 kDa (hCAP-18). The major effector
molecule of hCAP-18 is C-terminus which begins with 2
leucines and 37 amino acid residues in length, so called LL-
37 (8). The antimicrobial activity of cathelicidins is only acti-
vated following proteolytic processing from the cathelin do-
main of the preproprotein by elastase or proteinase-3 (15-17).
LL-37 has broad-spectrum antimicrobial activity against
Gram-positive and Gram-negative bacteria such as S. aureus,
Pseudomonas aeruginosa, and E. coli, as well as against fungi
and enveloped viruses and expression of it is up-regulated
by inflammatory stimulants or injury such as microbial inva-
sion (18-20). Because LL-37 is widely distributed within skin
and mucosal epithelial tissues, as well as secretion such as
saliva and sweat, it is ideally situated to serve a sentinel role
as multifunctional effectors of innate immunity (4, 5, 16).
Beside this function, LL-37 can influence wound repair and
has been shown to have additional effects on the host. LL-37
up-regulates epithelial expressions of chemokine and chemokine
receptor genes, and itself acts as chemoattractant for neutro-
phils, monocytes, T cells and mast cells (21, 22).
We could observe that LL-37 expressions were up-regu-
lated by LPS stimulation and UVB irradiation in NHKs. In
RT-PCR analysis, at 6 hr and 12 hr post stimulation, LL-37
is more intensely expressed in LPS 2.5  g/mL stimulated
group but, at 24 hr post stimulation. LL-37 expression was
also markedly up-regulated by UVB irradiation with dose
of 20 mJ/cm2. However, expressions of LL-37 were not seen
in HaCaT cells.
Production patterns of LL-37 proteins were also identified
in Western blotting in NHKs. The maximum expressions
of LL-37 protein in NHKs were obtained with LPS stimu-
lation at 6 hr post stimulation. But, LL-37 expressions were
not enhanced even in stimulated HaCaT cells. In immuno-
histochemical staining analysis, UVB irradiated and LPS
treated groups were stained stronger than those of control.
However, in HaCaT cells, the study showed no staining.
We obtained the results that expressions of LL-37 were up-
regulated in NHKs by UVB irradiation and LPS stimulation.
No expressions of LL-37 in HaCaT cells even exposure to
UVB irradiation and LPS could be supposed on the assump-
tion of the following hypotheses. First, these results may be
due to different feature of differentiation between these two
groups. That is NHKs are gradually differentiating, whereas
HaCaT cells are really not differentiating any more. Such
dissimilar differentiation property may have exerted influence
on the expression of LL-37. In the second place, we could
presume that there were genetic defect encoding LL-37 or
unknown interference on transcription of LL-37 in HaCaT
cells. The third, we assumed that relative deficiency of immu-
nity in perinatal period brought about these results. Dorschner
et al. (23) reported that human cathelicidin expression is sig-
nificantly elevated in the perinatal period when compared
with adult skin and expression is present in the absence of
inflammation. In consideration of relative deficiency in cel-
lular immune function in neonates, it is attractive to specu-
late that augmented innate antimicrobial peptide defense
mechanism is beneficial to the newborn and provides essen-
tial level of microbial protection. In this study NHKs were
prepared from neonatal foreskin, so LL-37 is more prominently
expressed in NHKs independent of stimulation in compari-
son with HaCaT cells.
Atopic dermatitis is very common skin disease known to
be associated with a high prevalence of skin infections, how-
ever, in psoriasis only small proportion of patients are suffering
from infection. In atopic dermatitis, inflammation is medi-
ated by type 2 helper T cells which can produce IL-4, IL-13
whereas inflammation of psoriasis is mediated by type 1 helper
T cells and epidermis is thickened owing to increased differ-
entiated keratinocytes (12-14). And LL-37 has potential bind-
ing sites for acute phase response factor (APRF) and IL-6, in
its promoter and intron regions (24). Interestingly, increased
levels of IL-6 and IL-8 have been identified in psoriatic skin.
Therefore, bacterial infection is not severe problem in psori-
asis although the barrier function of psoriatic skin is disrupt-
ed because of increased expression of AMPs (12). However
these peptides are significantly decreased in acute and chronic
lesions of atopic dermatitis. Decreased expressions of AMPs
may account for the susceptibility of atopic dermatitis patients
to skin infection and inhibitory effects of IL-4 and IL-13 on
HBD-2 expression may account for this finding (13, 14, 25).
The results of immunostaining for LL-37 in the sample of
psoriatic lesions and atopic dermatitis lesions were consistent
with previous study showing that psoriatic lesions have greater
expression of LL-37 than atopic dermatitis. In a word, signif-
icant difference of LL-37 expression between psoriasis and
atopic dermatitis may be due to distinct cytokine profiles
and difference of epidermal differentiation status.
With our experiments, we were able to demonstrate en-
hanced expression of LL-37 after LPS stimulation and UVB
irradiation in both mRNA and protein level and confirmed
that LL-37 expression is induced by inflammatory stimula-
tions. And LL-37 expressions were also affected by cell dif-
ferentiation status. LL-37 expressions were identified only
in NHKs which are gradually differentiated cells and more
abundant in the epidermis of psoriasis. In summary, we could
understand susceptibility difference to infection in atopic
dermatitis and psoriasis that show different epidermal differ-
entiation status and concluded that induced LL-37 may con-
tribute to the skin immunity against various environmental
insults. 
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